The global market for Compound Paracetamol and Amantadine Hydrochloride Capsules was valued at US$ 88.1 million in the year 2024 and is projected to reach a revised size of US$ 117 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Compound Paracetamol and Amantadine Hydrochloride Capsules Market

Compound Paracetamol and Amantadine Hydrochloride Capsules are a compound preparation containing acetaminophen and amantadine hydrochloride as the main ingredients, which are widely used to relieve fever, headache, nasal congestion, sneezing, sore throat and other symptoms caused by the common cold or influenza. This medicine may also contain other auxiliary ingredients such as antihistamines or decongestants to further reduce allergic reactions and swelling of the nasal mucosa.

North American market for Compound Paracetamol and Amantadine Hydrochloride Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Compound Paracetamol and Amantadine Hydrochloride Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules include Jinan Hengji Pharmaceutical Co., Ltd., Hainan Haili Pharmaceutical Co., Ltd., Jilin Huawei Pharmaceutical Co., Ltd., Zhejiang Shapuaisi Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., Shaanxi Pharmaceutical Co., Ltd., Ningbo Shuangwei Pharmaceutical Co., Ltd., Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd., Jiangxi Xinglin Baima Pharmaceutical Co., Ltd., Zhejiang Yafeng Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Compound Paracetamol and Amantadine Hydrochloride Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Paracetamol and Amantadine Hydrochloride Capsules.

The Compound Paracetamol and Amantadine Hydrochloride Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compound Paracetamol and Amantadine Hydrochloride Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Compound Paracetamol and Amantadine Hydrochloride Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Compound Paracetamol and Amantadine Hydrochloride Capsules Market Report

Report Metric	Details
Report Name	Compound Paracetamol and Amantadine Hydrochloride Capsules Market
Accounted market size in year	US$ 88.1 million
Forecasted market size in 2031	US$ 117 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Pack of 10 Tablets Pack of 12 Tablets Others
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Jinan Hengji Pharmaceutical Co., Ltd., Hainan Haili Pharmaceutical Co., Ltd., Jilin Huawei Pharmaceutical Co., Ltd., Zhejiang Shapuaisi Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., Shaanxi Pharmaceutical Co., Ltd., Ningbo Shuangwei Pharmaceutical Co., Ltd., Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd., Jiangxi Xinglin Baima Pharmaceutical Co., Ltd., Zhejiang Yafeng Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group, Chongqing Tianzhi Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd., Heilongjiang Tianhong Pharmaceutical Co., Ltd., Shandong Sibond Pharmaceutical Co., Ltd., Xianzhen Pharmaceutical Group, Sichuan Kelun Pharmaceutical Co., Ltd., Changchun Bethune Pharmaceutical Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd., Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Compound Paracetamol and Amantadine Hydrochloride Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Compound Paracetamol and Amantadine Hydrochloride Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Compound Paracetamol and Amantadine Hydrochloride Capsules Market growing?

Ans: The Compound Paracetamol and Amantadine Hydrochloride Capsules Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Compound Paracetamol and Amantadine Hydrochloride Capsules Market size in 2031?

Ans: The Compound Paracetamol and Amantadine Hydrochloride Capsules Market size in 2031 will be US$ 117 million.

Who are the main players in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market report?

Ans: The main players in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market are Jinan Hengji Pharmaceutical Co., Ltd., Hainan Haili Pharmaceutical Co., Ltd., Jilin Huawei Pharmaceutical Co., Ltd., Zhejiang Shapuaisi Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., Shaanxi Pharmaceutical Co., Ltd., Ningbo Shuangwei Pharmaceutical Co., Ltd., Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd., Jiangxi Xinglin Baima Pharmaceutical Co., Ltd., Zhejiang Yafeng Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group, Chongqing Tianzhi Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd., Heilongjiang Tianhong Pharmaceutical Co., Ltd., Shandong Sibond Pharmaceutical Co., Ltd., Xianzhen Pharmaceutical Group, Sichuan Kelun Pharmaceutical Co., Ltd., Changchun Bethune Pharmaceutical Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd., Tonghua Jinkaiwei Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market report?

Ans: The Applications covered in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market report?

Ans: The Types covered in the Compound Paracetamol and Amantadine Hydrochloride Capsules Market report are Pack of 10 Tablets, Pack of 12 Tablets, Others

1 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Overview

1.1 Product Definition

1.2 Compound Paracetamol and Amantadine Hydrochloride Capsules by Type

1.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 Pack of 10 Tablets

1.2.3 Pack of 12 Tablets

1.2.4 Others

1.3 Compound Paracetamol and Amantadine Hydrochloride Capsules by Application

1.3.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size Estimates and Forecasts

1.4.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue 2020-2031

1.4.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales 2020-2031

1.4.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Competition by Manufacturers

2.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Compound Paracetamol and Amantadine Hydrochloride Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Product Type & Application

2.7 Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Date of Enter into This Industry

2.8 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Competitive Situation and Trends

2.8.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Compound Paracetamol and Amantadine Hydrochloride Capsules Players Market Share by Revenue

2.8.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Scenario by Region

3.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region: 2020-2031

3.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region: 2020-2025

3.2.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region: 2026-2031

3.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region: 2020-2031

3.3.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region: 2020-2025

3.3.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region: 2026-2031

3.4 North America Compound Paracetamol and Amantadine Hydrochloride Capsules Market Facts & Figures by Country

3.4.1 North America Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2031)

3.4.3 North America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Market Facts & Figures by Country

3.5.1 Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2031)

3.5.3 Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Market Facts & Figures by Country

3.7.1 Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2031)

3.7.3 Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Type (2020-2031)

4.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Type (2020-2025)

4.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Type (2026-2031)

4.1.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Type (2020-2031)

4.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Type (2020-2031)

4.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Type (2020-2025)

4.2.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Type (2026-2031)

4.2.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Application (2020-2031)

5.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Application (2020-2025)

5.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Application (2026-2031)

5.1.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Application (2020-2031)

5.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Application (2020-2031)

5.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Application (2020-2025)

5.2.2 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Application (2026-2031)

5.2.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Jinan Hengji Pharmaceutical Co., Ltd.

6.1.1 Jinan Hengji Pharmaceutical Co., Ltd. Company Information

6.1.2 Jinan Hengji Pharmaceutical Co., Ltd. Description and Business Overview

6.1.3 Jinan Hengji Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Jinan Hengji Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.1.5 Jinan Hengji Pharmaceutical Co., Ltd. Recent Developments/Updates

6.2 Hainan Haili Pharmaceutical Co., Ltd.

6.2.1 Hainan Haili Pharmaceutical Co., Ltd. Company Information

6.2.2 Hainan Haili Pharmaceutical Co., Ltd. Description and Business Overview

6.2.3 Hainan Haili Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hainan Haili Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.2.5 Hainan Haili Pharmaceutical Co., Ltd. Recent Developments/Updates

6.3 Jilin Huawei Pharmaceutical Co., Ltd.

6.3.1 Jilin Huawei Pharmaceutical Co., Ltd. Company Information

6.3.2 Jilin Huawei Pharmaceutical Co., Ltd. Description and Business Overview

6.3.3 Jilin Huawei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Jilin Huawei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.3.5 Jilin Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates

6.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

6.4.1 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information

6.4.2 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Description and Business Overview

6.4.3 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.4.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments/Updates

6.5 Good Doctor Pharmaceutical Group Co., Ltd.

6.5.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information

6.5.2 Good Doctor Pharmaceutical Group Co., Ltd. Description and Business Overview

6.5.3 Good Doctor Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Good Doctor Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.5.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.6 Shaanxi Pharmaceutical Co., Ltd.

6.6.1 Shaanxi Pharmaceutical Co., Ltd. Company Information

6.6.2 Shaanxi Pharmaceutical Co., Ltd. Description and Business Overview

6.6.3 Shaanxi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Shaanxi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.6.5 Shaanxi Pharmaceutical Co., Ltd. Recent Developments/Updates

6.7 Ningbo Shuangwei Pharmaceutical Co., Ltd.

6.7.1 Ningbo Shuangwei Pharmaceutical Co., Ltd. Company Information

6.7.2 Ningbo Shuangwei Pharmaceutical Co., Ltd. Description and Business Overview

6.7.3 Ningbo Shuangwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Ningbo Shuangwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.7.5 Ningbo Shuangwei Pharmaceutical Co., Ltd. Recent Developments/Updates

6.8 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd.

6.8.1 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Company Information

6.8.2 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Description and Business Overview

6.8.3 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.8.5 Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.9 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.

6.9.1 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Company Information

6.9.2 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Description and Business Overview

6.9.3 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.9.5 Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Recent Developments/Updates

6.10 Zhejiang Yafeng Pharmaceutical Co., Ltd.

6.10.1 Zhejiang Yafeng Pharmaceutical Co., Ltd. Company Information

6.10.2 Zhejiang Yafeng Pharmaceutical Co., Ltd. Description and Business Overview

6.10.3 Zhejiang Yafeng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Zhejiang Yafeng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.10.5 Zhejiang Yafeng Pharmaceutical Co., Ltd. Recent Developments/Updates

6.11 Sunflower Pharmaceutical Group

6.11.1 Sunflower Pharmaceutical Group Company Information

6.11.2 Sunflower Pharmaceutical Group Description and Business Overview

6.11.3 Sunflower Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sunflower Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.11.5 Sunflower Pharmaceutical Group Recent Developments/Updates

6.12 Chongqing Tianzhi Pharmaceutical Co., Ltd.

6.12.1 Chongqing Tianzhi Pharmaceutical Co., Ltd. Company Information

6.12.2 Chongqing Tianzhi Pharmaceutical Co., Ltd. Description and Business Overview

6.12.3 Chongqing Tianzhi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Chongqing Tianzhi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.12.5 Chongqing Tianzhi Pharmaceutical Co., Ltd. Recent Developments/Updates

6.13 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.

6.13.1 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information

6.13.2 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Description and Business Overview

6.13.3 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.13.5 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Developments/Updates

6.14 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

6.14.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information

6.14.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Description and Business Overview

6.14.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.14.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.14.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments/Updates

6.15 Heilongjiang Tianhong Pharmaceutical Co., Ltd.

6.15.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information

6.15.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Description and Business Overview

6.15.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.15.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments/Updates

6.16 Shandong Sibond Pharmaceutical Co., Ltd.

6.16.1 Shandong Sibond Pharmaceutical Co., Ltd. Company Information

6.16.2 Shandong Sibond Pharmaceutical Co., Ltd. Description and Business Overview

6.16.3 Shandong Sibond Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Shandong Sibond Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.16.5 Shandong Sibond Pharmaceutical Co., Ltd. Recent Developments/Updates

6.17 Xianzhen Pharmaceutical Group

6.17.1 Xianzhen Pharmaceutical Group Company Information

6.17.2 Xianzhen Pharmaceutical Group Description and Business Overview

6.17.3 Xianzhen Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Xianzhen Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.17.5 Xianzhen Pharmaceutical Group Recent Developments/Updates

6.18 Sichuan Kelun Pharmaceutical Co., Ltd.

6.18.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information

6.18.2 Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview

6.18.3 Sichuan Kelun Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Sichuan Kelun Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.18.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates

6.19 Changchun Bethune Pharmaceutical Co., Ltd.

6.19.1 Changchun Bethune Pharmaceutical Co., Ltd. Company Information

6.19.2 Changchun Bethune Pharmaceutical Co., Ltd. Description and Business Overview

6.19.3 Changchun Bethune Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Changchun Bethune Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.19.5 Changchun Bethune Pharmaceutical Co., Ltd. Recent Developments/Updates

6.20 Tonghua Dongbao Pharmaceutical Co., Ltd.

6.20.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Company Information

6.20.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Description and Business Overview

6.20.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.20.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.20.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates

6.21 Tonghua Jinkaiwei Pharmaceutical Co., Ltd.

6.21.1 Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Company Information

6.21.2 Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Description and Business Overview

6.21.3 Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)

6.21.4 Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product Portfolio

6.21.5 Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Compound Paracetamol and Amantadine Hydrochloride Capsules Industry Chain Analysis

7.2 Compound Paracetamol and Amantadine Hydrochloride Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Compound Paracetamol and Amantadine Hydrochloride Capsules Production Mode & Process Analysis

7.4 Compound Paracetamol and Amantadine Hydrochloride Capsules Sales and Marketing

7.4.1 Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Channels

7.4.2 Compound Paracetamol and Amantadine Hydrochloride Capsules Distributors

7.5 Compound Paracetamol and Amantadine Hydrochloride Capsules Customer Analysis

8 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Dynamics

8.1 Compound Paracetamol and Amantadine Hydrochloride Capsules Industry Trends

8.2 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Drivers

8.3 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Challenges

8.4 Compound Paracetamol and Amantadine Hydrochloride Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jinan Hengji Pharmaceutical Co., Ltd.

Hainan Haili Pharmaceutical Co., Ltd.

Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

Good Doctor Pharmaceutical Group Co., Ltd.

Ningbo Shuangwei Pharmaceutical Co., Ltd.

Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd.

Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.

Sunflower Pharmaceutical Group

Chongqing Tianzhi Pharmaceutical Co., Ltd.

Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Changchun Bethune Pharmaceutical Co., Ltd.

Tonghua Dongbao Pharmaceutical Co., Ltd.

Tonghua Jinkaiwei Pharmaceutical Co., Ltd.

Jilin Huawei Pharmaceutical Co., Ltd.

Shaanxi Pharmaceutical Co., Ltd.

Zhejiang Yafeng Pharmaceutical Co., Ltd.

Shandong Sibond Pharmaceutical Co., Ltd.

Xianzhen Pharmaceutical Group

List of Tables

Table 1. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Compound Paracetamol and Amantadine Hydrochloride Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Compound Paracetamol and Amantadine Hydrochloride Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Compound Paracetamol and Amantadine Hydrochloride Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Compound Paracetamol and Amantadine Hydrochloride Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compound Paracetamol and Amantadine Hydrochloride Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. Jinan Hengji Pharmaceutical Co., Ltd. Company Information

Table 71. Jinan Hengji Pharmaceutical Co., Ltd. Description and Business Overview

Table 72. Jinan Hengji Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Jinan Hengji Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 74. Jinan Hengji Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 75. Hainan Haili Pharmaceutical Co., Ltd. Company Information

Table 76. Hainan Haili Pharmaceutical Co., Ltd. Description and Business Overview

Table 77. Hainan Haili Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Hainan Haili Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 79. Hainan Haili Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 80. Jilin Huawei Pharmaceutical Co., Ltd. Company Information

Table 81. Jilin Huawei Pharmaceutical Co., Ltd. Description and Business Overview

Table 82. Jilin Huawei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Jilin Huawei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 84. Jilin Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 85. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information

Table 86. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Description and Business Overview

Table 87. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 89. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 90. Good Doctor Pharmaceutical Group Co., Ltd. Company Information

Table 91. Good Doctor Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 92. Good Doctor Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Good Doctor Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 94. Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 95. Shaanxi Pharmaceutical Co., Ltd. Company Information

Table 96. Shaanxi Pharmaceutical Co., Ltd. Description and Business Overview

Table 97. Shaanxi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Shaanxi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 99. Shaanxi Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 100. Ningbo Shuangwei Pharmaceutical Co., Ltd. Company Information

Table 101. Ningbo Shuangwei Pharmaceutical Co., Ltd. Description and Business Overview

Table 102. Ningbo Shuangwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Ningbo Shuangwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 104. Ningbo Shuangwei Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 105. Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Company Information

Table 106. Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Description and Business Overview

Table 107. Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 109. Guangxi Liangmianzhen Yikang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 110. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Company Information

Table 111. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Description and Business Overview

Table 112. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 114. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 115. Zhejiang Yafeng Pharmaceutical Co., Ltd. Company Information

Table 116. Zhejiang Yafeng Pharmaceutical Co., Ltd. Description and Business Overview

Table 117. Zhejiang Yafeng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Zhejiang Yafeng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 119. Zhejiang Yafeng Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 120. Sunflower Pharmaceutical Group Company Information

Table 121. Sunflower Pharmaceutical Group Description and Business Overview

Table 122. Sunflower Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Sunflower Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 124. Sunflower Pharmaceutical Group Recent Developments/Updates

Table 125. Chongqing Tianzhi Pharmaceutical Co., Ltd. Company Information

Table 126. Chongqing Tianzhi Pharmaceutical Co., Ltd. Description and Business Overview

Table 127. Chongqing Tianzhi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Chongqing Tianzhi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 129. Chongqing Tianzhi Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 130. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information

Table 131. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Description and Business Overview

Table 132. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 134. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 135. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information

Table 136. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Description and Business Overview

Table 137. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 139. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 140. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information

Table 141. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Description and Business Overview

Table 142. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 144. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 145. Shandong Sibond Pharmaceutical Co., Ltd. Company Information

Table 146. Shandong Sibond Pharmaceutical Co., Ltd. Description and Business Overview

Table 147. Shandong Sibond Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Shandong Sibond Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 149. Shandong Sibond Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 150. Xianzhen Pharmaceutical Group Company Information

Table 151. Xianzhen Pharmaceutical Group Description and Business Overview

Table 152. Xianzhen Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Xianzhen Pharmaceutical Group Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 154. Xianzhen Pharmaceutical Group Recent Developments/Updates

Table 155. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information

Table 156. Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview

Table 157. Sichuan Kelun Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 158. Sichuan Kelun Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 159. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 160. Changchun Bethune Pharmaceutical Co., Ltd. Company Information

Table 161. Changchun Bethune Pharmaceutical Co., Ltd. Description and Business Overview

Table 162. Changchun Bethune Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 163. Changchun Bethune Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 164. Changchun Bethune Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 165. Tonghua Dongbao Pharmaceutical Co., Ltd. Company Information

Table 166. Tonghua Dongbao Pharmaceutical Co., Ltd. Description and Business Overview

Table 167. Tonghua Dongbao Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 168. Tonghua Dongbao Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 169. Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 170. Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Company Information

Table 171. Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Description and Business Overview

Table 172. Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 173. Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Capsules Product

Table 174. Tonghua Jinkaiwei Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 175. Key Raw Materials Lists

Table 176. Raw Materials Key Suppliers Lists

Table 177. Compound Paracetamol and Amantadine Hydrochloride Capsules Distributors List

Table 178. Compound Paracetamol and Amantadine Hydrochloride Capsules Customers List

Table 179. Compound Paracetamol and Amantadine Hydrochloride Capsules Market Trends

Table 180. Compound Paracetamol and Amantadine Hydrochloride Capsules Market Drivers

Table 181. Compound Paracetamol and Amantadine Hydrochloride Capsules Market Challenges

Table 182. Compound Paracetamol and Amantadine Hydrochloride Capsules Market Restraints

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

Table 186. Authors List of This Report

List of Figures

Figure 1. Product Picture of Compound Paracetamol and Amantadine Hydrochloride Capsules

Figure 2. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Share by Type: 2024 & 2031

Figure 4. Pack of 10 Tablets Product Picture

Figure 5. Pack of 12 Tablets Product Picture

Figure 6. Others Product Picture

Figure 7. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size (2020-2031) & (US$ Million)

Figure 14. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Sales (2020-2031) & (K Units)

Figure 15. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Average Price (US$/Unit) & (2020-2031)

Figure 16. Compound Paracetamol and Amantadine Hydrochloride Capsules Report Years Considered

Figure 17. Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Share by Manufacturers in 2024

Figure 18. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Compound Paracetamol and Amantadine Hydrochloride Capsules Players: Market Share by Revenue in Compound Paracetamol and Amantadine Hydrochloride Capsules in 2024

Figure 20. Compound Paracetamol and Amantadine Hydrochloride Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Country (2020-2031)

Figure 23. North America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Country (2020-2031)

Figure 24. United States Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Country (2020-2031)

Figure 27. Europe Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Country (2020-2031)

Figure 28. Germany Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Region (2020-2031)

Figure 35. China Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Country (2020-2031)

Figure 43. Latin America Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Compound Paracetamol and Amantadine Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Compound Paracetamol and Amantadine Hydrochloride Capsules by Type (2020-2031)

Figure 54. Global Revenue Market Share of Compound Paracetamol and Amantadine Hydrochloride Capsules by Type (2020-2031)

Figure 55. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Compound Paracetamol and Amantadine Hydrochloride Capsules by Application (2020-2031)

Figure 57. Global Revenue Market Share of Compound Paracetamol and Amantadine Hydrochloride Capsules by Application (2020-2031)

Figure 58. Global Compound Paracetamol and Amantadine Hydrochloride Capsules Price (US$/Unit) by Application (2020-2031)

Figure 59. Compound Paracetamol and Amantadine Hydrochloride Capsules Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions